Skip to Main Content

Paper Details

miR30a inhibits LOX expression and anaplastic thyroid cancer progression.
Cancer Res
60
2015
ATC, Anaplastic thyroid cancer, LOX, anaplastic thyroid cancer, cancers, differentiated thyroid cancer, human, lysyl, lysyl oxidase, malignancies, miR30a, miRNA, miRNA miR30a, normal, thyroid cancer
Animals, Cell Movement, Disease Progression, Down-Regulation, Female, Gene Knockdown Techniques, Heterografts, Humans, Mice, Mice, Nude, MicroRNAs, Neoplasm Invasiveness, Protein-Lysine 6-Oxidase, Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms, Transfection
Author NameAffiliation
Myriem BoufraqechCenter for Cancer Research
Myriem BoufraqechCenter for Cancer Research
Naris NilubolCenter for Cancer Research
Naris NilubolCenter for Cancer Research
Lisa ZhangCenter for Cancer Research
Lisa ZhangCenter for Cancer Research
Sudheer Kumar GaraCenter for Cancer Research
Sudheer Kumar GaraCenter for Cancer Research
Samira M SadowskiCenter for Cancer Research
Samira M SadowskiCenter for Cancer Research
Amit MehtaCenter for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth
Amit MehtaCenter for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth
Mei HeCenter for Cancer Research
Mei HeCenter for Cancer Research
Sean DavisCenter for Cancer Research, National Cancer Institute
Susan R DavisCenter for Cancer Research, National Cancer Institute
Jennifer L DreilingCenter for Cancer Research
Jennifer L DreilingCenter for Cancer Research
John A CoplandMayo Clinic
John A CoplandMayo Clinic
Robert C SmallridgeMayo Clinic
Robert C SmallridgeMayo Clinic
Martha QuezadoCenter for Cancer Research
Martha QuezadoCenter for Cancer Research
Electron KebebewCenter for Cancer Research
Electron KebebewCenter for Cancer Research
  • 1 - 26

Datasets

Release 1.2